Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-17-028202
Filing Date
2017-05-17
Accepted
2017-05-17 17:16:36
Documents
85
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v466981_10k.htm 10-K 1259818
2 EXHIBIT 21.1 v466981_ex21-1.htm EX-21.1 2613
3 EXHIBIT 23.1 v466981_ex23-1.htm EX-23.1 2440
4 EXHIBIT 31.1 v466981_ex31-1.htm EX-31.1 8506
5 EXHIBIT 31.2 v466981_ex31-2.htm EX-31.2 8578
6 EXHIBIT 32.1 v466981_ex32-1.htm EX-32.1 4435
7 EXHIBIT 32.2 v466981_ex32-2.htm EX-32.2 4474
  Complete submission text file 0001144204-17-028202.txt   9107065

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT imnp-20161231.xml EX-101.INS 1958743
9 XBRL TAXONOMY EXTENSION SCHEMA imnp-20161231.xsd EX-101.SCH 89778
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imnp-20161231_cal.xml EX-101.CAL 57936
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imnp-20161231_def.xml EX-101.DEF 587777
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE imnp-20161231_lab.xml EX-101.LAB 616407
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imnp-20161231_pre.xml EX-101.PRE 634983
Mailing Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016 646-440-9310
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

EIN.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36602 | Film No.: 17852635
SIC: 2834 Pharmaceutical Preparations